[1] Pfaller MA,Diekema DJ.Epidemiology of invasive mycoses in North America[J].Crit Rev Microbiol,2010,36(1):1-53.
[2] U.S.Deparment of Health and Human Services:Centers for Disease Control and Prevention.Antibiotic resistance threats in the United States,2013[R].Atlanta,USA:CDC,2013.
[3] Cowen LE,Steinbach WJ.Stress,drugs,and evolution:the role of cellular signaling in fungal drug resistance[J].Eukaryot Cell,2008,7(5):747-764.
[4] Cowen LE.The evolution of fungal drug resistance:modulating the trajectory from genotype to phenotype[J].Nat Rev Microbiol,2008,6(3):187-198.
[5] Leach MD,Klipp E,Cowen LE,et al.Fungal Hsp90:a biological transistor that tunes cellular outputs to thermal inputs[J].Nat Rev Microbiol,2012,10(10):693-704.
[6] Rutherford SL,Lindquist S.Hsp90 as a capacitor for morphological evolution[J].Nature,1998,396(6709):336-342.
[7] Sangster TA,Lindquist S,Queitsch C.Under cover:causes,effects and implications of Hsp90-mediated genetic capacitance[J].Bioessays,2004,26(4):348-362.
[8] Queitsch C,Sangster TA,Lindquist S.Hsp90 as a capacitor of phenotypic variation[J].Nature,2002,417(6889):618-624.
[9] Cowen LE,Lindquist S.Hsp90 potentiates the rapid evolution of new traits:drug resistance in diverse fungi[J].Science,2005,309(5744):2185-2189.
[10] Jarosz DF,Lindquist S.Hsp90 and environmental stress transform the adaptive value of natural genetic variation[J].Science,2010,330(6012):1820-1824.
[11] Miller LG,Hajjeh RA,Edwards JE Jr.Estimating the cost of nosocomial candidemia in the united states[J].Clin Infect Dis,2001,32(7):1110.
[12] Cowen LE.Hsp90 orchestrates stress response signaling governing fungal drug resistance[J].PLoS Pathog,2009,5(8):e1000471.
[13] Singh SD,Robbins N,Zaas AK,et al.Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin[J].PLoS Pathog,2009,5(7):e1000532.
[14] Singh-Babak SD,Babak T,Diezmann S,et al.Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata[J].PLoS Pathog,2012,8(5):e1002718.
[15] Lamoth F,Juvvadi PR,Gehrke C,et al.In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole-and echinocandin-resistant strains[J].Antimicrob Agents Chemother,2013,57(2):1035-1039.
[16] D'enfert C.Biofilms and their role in the resistance of pathogenic Candida to antifungal agents[J].Curr Drug Targets,2006,7(4):465-470.
[17] Robbins N,Uppuluri P,Nett J,et al.Hsp90 governs dispersion and drug resistance of fungal biofilms[J].PLoS Pathog,2011,7(9):e1002257.
[18] Diezmann S,Leach MD,Cowen LE.Functional Divergence of Hsp90 Genetic Interactions in Biofilm and Planktonic Cellular States[J].PLoS One,2015,10(9):e0137947.
[19] Noble SM,French S,Kohn LA,et al.Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity[J].Nat Genet,2010,42(7):590-598.
[20] Gow NA,Van De Veerdonk FL,Brown AJ,et al.Candida albicans morphogenesis and host defence:discriminating invasion from colonization[J].Nat Rev Microbiol,2012,10(2):112-122.
[21] Shapiro RS,Uppuluri P,Zaas AK,et al.Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling[J].Curr Biol,2009,19(8):621-629.
[22] Kovacs JJ,Murphy PJ,Gaillard S,et al.HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor[J].Mol Cell,2005,18(5):601-607.
[23] Scroggins BT,Robzyk K,Wang D,et al.An acetylation site in the middle domain of Hsp90 regulates chaperone function[J].Mol Cell,2007,25(1):151-159.
[24] Mollapour M,Tsutsumi S,Truman AW,et al.Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity[J].Mol Cell,2011,41(6):672-681.
[25] Diezmann S,Michaut M,Shapiro RS,et al.Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry[J].PLoS Genet,2012,8(3):e1002562.
[26] Bruno VM,Mitchell AP.Regulation of azole drug susceptibility by Candida albicans protein kinase CK2[J].Mol Microbiol,2005,56(2):559-573.
[27] Robbins N,Leach MD,Cowen LE.Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance[J].Cell Rep,2012,2(4):878-888.
[28] Shapiro RS,Zaas AK,Betancourt-Quiroz M,et al.The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance[J].PLoS One,2012,7(9):e44734.
[29] Steinbach WJ,Cramer RA Jr,Perfect BZ,et al.Calcineurin controls growth,morphology,and pathogenicity in Aspergillus fumigatus[J].Eukaryot Cell,2006,5(7):1091-1103.
[30] Miyazaki T,Yamauchi S,Inamine T,et al.Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata[J].Antimicrob Agents Chemother,2010,54(4):1639-1643.
[31] Lafayette SL,Collins C,Zaas AK,et al.PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1,calcineurin,and Hsp90[J].PLoS Pathog,2010,6(8):e1001069.
[32] Millson SH,Truman AW,King V,et al.A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase,Slt2p(Mpk1p)[J].Eukaryot Cell,2005,4(5):849-860.
[33] Gerik KJ,Donlin MJ,Soto CE,et al.Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans[J].Mol Microbiol,2005,58(2):393-408.
[34] Hodgetts S,Nooney L,Al-Akeel R,et al.Efungumab and caspofungin:pre-clinical data supporting synergy[J].J Antimicrob Chemother,2008,61(5):1132-1139.
[35] http://www.emea.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC500017175.pdf.
[36] Louie A,Stein DS,Zack JZ,et al.Dose range evaluation of Mycograb C28Y variant,a human recombinant antibody fragment to heat shock protein 90,in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis[J].Antimicrob Agents Chemother,2011,55(7):3295-3304.
[37] Richie DL,Ghannoum MA,Isham N,et al.Nonspecific effect of Mycograb on amphotericin B MIC[J].Antimicrob Agents Chemother,2012,56(7):3963-3964.
[38] Cowen LE.The fungal Achilles' heel:targeting Hsp90 to cripple fungal pathogens[J].Curr Opin Microbiol,2013,16(4):377-384.
[39] Lamoth F,Alexander BD,Juvvadi PR,et al.Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species[J].J Antimicrob Chemother,2015,70(5):1408-1411.
[40] Southworth DR,Agard DA.Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle[J].Mol Cell,2008,32(5):631-640. |